Achromatopsia, or rod monochromacy, is a congenital, autosomal recessive visual disorder characterized by total color blindness, photophobia, reduced visual acuity and nystagmus.
2 3 4 5 Although disease prevalence is rare (1:30,000), founder effects can lead to areas with significant populations of affected individuals.
5 In achromats, rod photoreceptor function is normal while cone photoreceptors appear viable but fail to generate an electrical response. Mutations in the α-subunit of cone transducin causally link with human achromatopsia. The zebrafish mutant
nof represents an in vivo model of achromatopsia, with loss of cone visual function due to mutations in the α-subunit of cone transducin.
24 In the current study, we showed that cone visual function can be restored in homozygous
nof mutants by directing transgenic expression of wild-type TαC cDNA under control of the 3.2-kb cone-specific promoter. The rescue frequency was moderate at 14%. However, this is expected, as we evaluated the rescue frequency in transiently transfected embryos. This random integration procedure is relatively inefficient and results in larvae with mosaic expression of the transgene
(Fig. 1D) . Small patches of rescued cells in G
0 larvae are not likely to restore a functional OKR response. However, even moderate rescue provides proof of principle that monogenic achromatopsia can be overcome in vivo. We speculate that human achromatopsia can be overcome by gene therapy approaches, even when performed on affected adults, as there is no retinal degeneration.
In this study we identified a promoter fragment capable of directing cone-specific expression in vivo. The robust and specific expression of EGFP in cone photoreceptors enables facile monitoring of cone photoreceptor integrity. Incorporation of this transgenic line into forward genetic studies and expression profiling of purified populations of cone photoreceptors will uncover novel determinants of cone photoreceptor function and survival. These factors will help decipher the molecular genetics of cone photoreceptors.
The authors thank Alfonso Blanco, Paulette Brunner, Daniel Oprian, Padraig O’Murchu, and Laura Swaim for technical assistance; Tom Vihtelic and David Hyde for zebrafish opsin antibodies; and the Zebrafish International Resource Center for the monoclonal antibody zpr1.